Nasdaq:EURK
Eureka Acquisition Corp
A Nasdaq-listed SPAC (EURK) with substantial cash reserves seeking a merger target to transform into a fully operational business.
Key Metrics
Investment Thesis
Bull Case
EURK offers exposure to a potential high-growth technology or healthcare company at a valuation that excludes the premium of an IPO; The substantial cash position provides a safety buffer against market downturns while searching for a target; Investors gain early access to companies before they are fully mature and publicly traded.
Bear Case
The lack of revenue and zero gross profit indicates no operational business currently exists, making valuation entirely speculative based on merger potential; High negative cash flow from operations suggests significant administrative costs relative to the minimal asset base; There is a substantial risk of the SPAC failing to complete a merger, resulting in total loss of invested capital.
About Eureka Acquisition Corp
EURK (Eureka Acquisition Corp) is a special purpose acquisition company (SPAC) focused on identifying and merging with promising businesses in the technology or healthcare sectors. Currently operating with minimal revenue but significant cash reserves, the entity maintains a strategic position to execute its merger objectives. The company serves potential target markets through its SPAC structure, aiming to provide capital for high-growth ventures.
Analysis
Management Discussion
Despite reporting a net profit of $1.4M in 2025, the company shows a significant decrease in ending cash to $51.4k compared to beginning cash, indicating heavy financing outflows or specific transaction costs not fully reflected in standard operating metrics. The financial profile is typical for a SPAC pre-merger, where profits may arise from interest income on trust accounts rather than core business operations, and the primary focus remains capital preservation for a future business combination.
Industry Overview
The SPAC market has evolved to favor companies that can quickly identify and close on high-quality targets rather than relying solely on market speculation. Investors are increasingly scrutinizing the track record of sponsors and the quality of potential PIPE (Private Investment in Public Equity) commitments for these entities. Regulatory oversight remains strict, ensuring that new listings meet public company disclosure standards before trading commences.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2024 | 2025 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Expenses | $354.1K | $859.7K |
| Operating Income | $-354.1K | $-859.7K |
| G&A | $354.1K | $859.7K |
| Stock-Based Comp | $38.5K | — |
| Other OpEx | $0 | $0 |
| Non-Operating Income | $609.8K | $2.2M |
| Interest Income | $609.8K | $2.2M |
| Pre-Tax Income | $255.7K | $1.4M |
| Income Tax | $0 | $0 |
| Continuing Ops | $255.7K | $1.4M |
| Discontinued Ops | $0 | $0 |
| Net Income | $255.7K | $1.4M |
| Minority Interest | $0 | $0 |
| Net to Common | $255.7K | $1.4M |
| Metric | 2024 | 2025 |
|---|---|---|
| Current Assets | $734.2K | $99.3K |
| Long-Term Assets | $58.1M | $31.3M |
| Total Assets | $58.8M | $31.4M |
| Current Liabilities | $49.7K | $724.6K |
| Long-Term Liabilities | $0 | $0 |
| Total Liabilities | $49.7K | $724.6K |
| Shareholders' Equity | $58.8M | $30.7M |
| Paid-In Capital | $2.6M | — |
| Retained Earnings | $250.4K | $-625.5K |
| Total L&E | $58.8M | $31.4M |
| Metric | 2024 | 2025 |
|---|---|---|
| Net Income (CFO) | $255.7K | $1.4M |
| Non-Cash Adjustments | $-604.6K | $-2.2M |
| Working Capital Changes | $66.4K | $158.9K |
| Cash from Operations | $-282.5K | $-668.9K |
| Cash from Investing | $-57.5M | $29.0M |
| Cash from Financing | $58.5M | $-29.0M |
| FX Effect | $0 | $0 |
| Net Change in Cash | $670.4K | $-618.9K |
| Beginning Cash | $0 | $670.4K |
| Ending Cash | $670.4K | $51.4K |
Frequently Asked Questions
How does Eureka Acquisition Corp make money?
Primary segment: SPAC Merger Activities; Secondary segment: Cash and Short-Term Investments; Tertiary segment: General and Administrative Operations for corporate governance.
What are the main risks for EURK?
Failure to identify a suitable merger target within the required timeframe leading to liquidation or reverse merger delays; Market volatility affecting SPAC valuations and investor sentiment; Regulatory hurdles associated with SEC review of proposed business combinations; Potential dilution from future equity offerings if cash reserves are depleted before a deal closes.
What is EURK's competitive advantage?
Access to immediate capital through the SPAC trust structure allowing rapid deployment upon merger completion; Strong liquidity position with over $51M in cash providing flexibility for deal-making; Minimal ongoing operational burn rate prior to merger reduces dilution risks.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.